000 01728 a2200493 4500
005 20250515150716.0
264 0 _c20091125
008 200911s 0 0 eng d
022 _a1357-0560
024 7 _a10.1007/s12032-008-9131-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIbrahim, Ezzeldin
245 0 0 _aBasal vs. luminal A breast cancer subtypes: a matched case-control study using estrogen receptor, progesterone receptor, and HER-2 as surrogate markers.
_h[electronic resource]
260 _bMedical oncology (Northwood, London, England)
_c2009
300 _a372-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnalysis of Variance
650 0 4 _aBiomarkers, Tumor
_xmetabolism
650 0 4 _aBreast Neoplasms
_xclassification
650 0 4 _aCase-Control Studies
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aKaplan-Meier Estimate
650 0 4 _aLogistic Models
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Metastasis
650 0 4 _aProportional Hazards Models
650 0 4 _aReceptor, ErbB-2
_xmetabolism
650 0 4 _aReceptors, Estrogen
_xmetabolism
650 0 4 _aReceptors, Progesterone
_xmetabolism
700 1 _aAl-Gahmi, Aboelkhair M
700 1 _aZeenelin, Ahmed A
700 1 _aZekri, Jamal M
700 1 _aElkhodary, Tawfik R
700 1 _aGaballa, Hussein E
700 1 _aFawzy, Ehab E
700 1 _aEl sayed, Mohamed E
700 1 _aAlzahrani, Mohamed S
773 0 _tMedical oncology (Northwood, London, England)
_gvol. 26
_gno. 3
_gp. 372-8
856 4 0 _uhttps://doi.org/10.1007/s12032-008-9131-6
_zAvailable from publisher's website
999 _c18490477
_d18490477